RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
- Conditions
- Atrial Fibrillation
- Interventions
- Registration Number
- NCT00808067
- Lead Sponsor
- Boehringer Ingelheim
- Brief Summary
The purposes of this study are:
1. To evaluate the long-term safety of dabigatran etexilate
2. To assess the effect of a knowledge translation intervention on patient outcomes
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5897
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description dabigatran dose 2 dabigatran dose 2 dabigatran low dose twice daily dabigatran dose 1 dabigatran dose 1 dabigatran high dose twice daily
- Primary Outcome Measures
Name Time Method Major Bleeding, Annualized Rate of Subjects With Major Bleeds up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Major bleeding must have satisfied one or more of the following criteria:
* Bleeding associated with a reduction in hemoglobin of at least 20 g/L
* Required transfusion of at least 2 units of blood or packed cells
* Symptomatic bleeding in a critical area or organ: intraocular, intraspinal, intramuscular with compartment syndrome, retroperitoneal, intra-articular, pericardial, gastrointestinal
Major bleed were classified as life-threatening if they met one or more of the following criteria:
* Reduction in hemoglobin of at least 50 g/L
* Transfusion of at least 4 units of blood or packed cells
* Symptomatic intracranial bleeding, either subdural or intracerebral
* Associated with hypotension requiring use of intravenous inotropic agents
* Required surgical intervention to stop bleeding
* Resulted in death
- Secondary Outcome Measures
Name Time Method Stroke, Annualized Rate of Subjects With Stroke up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Stroke was an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke was categorized as ischemic or hemorrhagic or cause unknown based on computerized tomography (CT), magnetic resonance (MR) scanning or autopsy. Fatal stroke was defined as death from any cause within 30 days of stroke. Severity of stroke was assessed by modified Rankin score at discharge from hospitalNon CNS Systemic Embolism (SEE), Annualized Rate of Subjects With Non-CNS SEE up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Systemic embolism was an acute vascular occlusion of the extremities or any organ (kidneys, mesenteric arteries, spleen, retina or grafts), and was to be documented by angiography, surgery, scintigraphy, or autopsy.Pulmonary Embolism (PE), Annualized Rate of Subjects With PE up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Pulmonary Embolism was generally documented by one of the following:
1. an intraluminal filling defect in segmental or more proximal branches on spiral CT scan
2. an intraluminal filling defect or an extension of an existing defect or a sudden cutoff of vessels more than 2.5 mm in diameter on the pulmonary angiogram
3. a perfusion defect of at least 75% of a segment with a local normal ventilation result (high-probability) on ventilation/perfusion lung scan (VPLS)
4. inconclusive spiral CT, pulmonary angiography or lung scintigraphy with demonstration of DVT in the lower extremities by compression ultrasound or venography.Acute Myocardial Infarction (MI), Annualized Rate of Subjects With MI up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
a. In subjects not undergoing PCI or CABG a subject should have fulfilled at least 2 of the following: i. Typical prolonged severe chest pain or related symptoms or signs suggestive of MI. ii. Elevation of troponin or CK-MB to more than upper level of normal (ULN) or, if CK-MB was elevated at baseline, re-elevation to more than 50% increase above the previous level. iii. Development of significant Q-waves in at least 2 adjacent ECG leads. b. After percutaneous coronary intervention (within 24h). c. After coronary artery bypass grafting (within 72h). d. Silent myocardial infarction. e. Myocardial infarction could also have been demonstrated at autopsy.Deep Vein Thrombosis, Annualized Rate of Subjects With DVT up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Deep Vein Thrombosis (DVT) was generally documented by one of the following:
1. abnormal compression ultrasound (CUS),
2. an intraluminal filling defect on venography.Death, Annualized Rate of Subject Death up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Deaths were classified as being vascular (sudden/arrhythmic, pump failure death, or other vascular, including bleeding) or non-vascular, due to other specified causes (e.g., malignancy), or of unknown etiology.Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE) up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE) and All Cause Death up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction, Vascular Death up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction (MI), All Cause Death and Major Bleed up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Annualized Rate of Subjects With Minor Bleeds up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Minor bleeds were clinical bleeds that did not fulfill the criteria for major bleeds. Minor bleeds were classified as associated with study medication discontinuation (temporary or permanent) or not.Annualized Rate of Subjects With Any Bleeds (Major Plus Minor) up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Annualized Rate of Subjects With Intra-Cranial Hemorrhage (ICH) up to 43 months Annualized event rate (%) = 100 \* No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
Trial Locations
- Locations (567)
1160.71.0119 Boehringer Ingelheim Investigational Site
🇺🇸Tupelo, Mississippi, United States
1160.71.0038 Boehringer Ingelheim Investigational Site
🇺🇸Hot Springs, Arkansas, United States
1160.71.0482 Boehringer Ingelheim Investigational Site
🇺🇸Guilford, Connecticut, United States
1160.71.0302 Boehringer Ingelheim Investigational Site
🇺🇸Jonesboro, Arkansas, United States
1160.71.0278 Boehringer Ingelheim Investigational Site
🇺🇸Bridgeport, Connecticut, United States
1160.71.0047 Boehringer Ingelheim Investigational Site
🇺🇸Baltimore, Maryland, United States
1160.71.0096 Boehringer Ingelheim Investigational Site
🇺🇸Auburn, Maine, United States
1160.71.0346 Boehringer Ingelheim Investigational Site
🇺🇸Henderson, Nevada, United States
1160.71.0177 Boehringer Ingelheim Investigational Site
🇺🇸Rockville, Maryland, United States
1160.71.0052 Boehringer Ingelheim Investigational Site
🇺🇸Westminster, Maryland, United States
1160.71.0073 Boehringer Ingelheim Investigational Site
🇺🇸Salisbury, Maryland, United States
1160.71.0027 Boehringer Ingelheim Investigational Site
🇺🇸Kalispell, Montana, United States
1160.71.0207 Boehringer Ingelheim Investigational Site
🇺🇸Salisbury, Maryland, United States
1160.71.0196 Boehringer Ingelheim Investigational Site
🇺🇸Takoma Park, Maryland, United States
1160.71.0221 Boehringer Ingelheim Investigational Site
🇺🇸Cherry Hill, New Jersey, United States
1160.71.0187 Boehringer Ingelheim Investigational Site
🇺🇸Towson, Maryland, United States
1160.71.0392 Boehringer Ingelheim Investigational Site
🇺🇸Ocean, New Jersey, United States
1160.71.0313 Boehringer Ingelheim Investigational Site
🇺🇸Greenville, South Carolina, United States
1160.71.0084 Boehringer Ingelheim Investigational Site
🇺🇸Chattanooga, Tennessee, United States
1160.71.0169 Boehringer Ingelheim Investigational Site
🇺🇸Clarksburg, West Virginia, United States
1160.71.0507 Boehringer Ingelheim Investigational Site
🇦🇺Launceston, Tasmania, Australia
1160.71.0571 Boehringer Ingelheim Investigational Site
🇧🇪Brussel, Belgium
1160.71.0578 Boehringer Ingelheim Investigational Site
🇧🇪Genk, Belgium
1160.71.0587 Boehringer Ingelheim Investigational Site
🇧🇪Genk, Belgium
1160.71.0588 Boehringer Ingelheim Investigational Site
🇧🇪Gilly, Belgium
1160.71.0567 Boehringer Ingelheim Investigational Site
🇧🇪Oostende, Belgium
1160.71.0570 Boehringer Ingelheim Investigational Site
🇧🇪Roeselare, Belgium
1160.71.0566 Boehringer Ingelheim Investigational Site
🇧🇪Tienen, Belgium
1160.71.0562 Boehringer Ingelheim Investigational Site
🇧🇪Turnhout, Belgium
1160.71.0617 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
1160.71.0703 Boehringer Ingelheim Investigational Site
🇨🇦Halifax, Nova Scotia, Canada
1160.71.0816 Boehringer Ingelheim Investigational Site
🇨🇿Modrice, Czech Republic
1160.71.0818 Boehringer Ingelheim Investigational Site
🇨🇿Pardubice, Czech Republic
1160.71.0817 Boehringer Ingelheim Investigational Site
🇨🇿Pribram, Czech Republic
1160.71.0699 Boehringer Ingelheim Investigational Site
🇨🇦St. Charles-Borromee, Quebec, Canada
1160.71.0859 Boehringer Ingelheim Investigational Site
🇫🇮Jyväskylä, Finland
1160.71.0819 Boehringer Ingelheim Investigational Site
🇨🇿Usti nad Orlici, Czech Republic
1160.71.0851 Boehringer Ingelheim Investigational Site
🇫🇮Helsinki, Finland
1160.71.0858 Boehringer Ingelheim Investigational Site
🇫🇮Pori, Finland
1160.71.0854 Boehringer Ingelheim Investigational Site
🇫🇮Oulu, Finland
1160.71.0910 Boehringer Ingelheim Investigational Site
🇬🇷Thiva, Greece
1160.71.0905 Boehringer Ingelheim Investigational Site
🇬🇷Voula - Athens, Greece
1160.71.1012 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºBudapest, Hungary
1160.71.1013 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºBudapest, Hungary
1160.71.1014 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºBudapest, Hungary
1160.71.1015 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºBudapest, Hungary
1160.71.1016 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºBudapest, Hungary
1160.71.1020 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºGyongyos, Hungary
1160.71.1018 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºPecs, Hungary
1160.71.1065 Boehringer Ingelheim Investigational Site
🇮🇳Bangalore, India
1160.71.1062 Boehringer Ingelheim Investigational Site
🇮🇳Hyderabad, India
1160.71.1067 Boehringer Ingelheim Investigational Site
🇮🇳Kerala, India
1160.71.1120 Boehringer Ingelheim Investigational Site
🇮🇱Tel Aviv, Israel
1160.71.1091 Boehringer Ingelheim Investigational Site
🇮🇱Haifa, Israel
1160.71.1113 Boehringer Ingelheim Investigational Site
🇮🇱Haifa, Israel
1160.71.1094 Boehringer Ingelheim Investigational Site
🇮🇱Ramat Gan, Israel
1160.71.1103 Boehringer Ingelheim Investigational Site
🇮🇱Safed, Israel
1160.71.1101 Boehringer Ingelheim Investigational Site
🇮🇱Jerusalem, Israel
1160.71.1093 Boehringer Ingelheim Investigational Site
🇮🇱Ramat Gan, Israel
1160.71.1095 Boehringer Ingelheim Investigational Site
🇮🇱Ramat Gan, Israel
1160.71.1100 Boehringer Ingelheim Investigational Site
🇮🇱Rehovot, Israel
1160.71.1122 Boehringer Ingelheim Investigational Site
🇮🇱Tel Aviv, Israel
1160.71.1107 Boehringer Ingelheim Investigational Site
🇮🇱Tel-Aviv, Israel
1160.71.1108 Boehringer Ingelheim Investigational Site
🇮🇱Tel-Aviv, Israel
1160.71.1109 Boehringer Ingelheim Investigational Site
🇮🇱Tel-Aviv, Israel
1160.71.1291 Boehringer Ingelheim Investigational Site
🇲🇾Kuala Lumpur, Malaysia
1160.71.1292 Boehringer Ingelheim Investigational Site
🇲🇾Kuala Lumpur, Malaysia
1160.71.1337 Boehringer Ingelheim Investigational Site
🇳🇱's Hertogenbosch, Netherlands
1160.71.1332 Boehringer Ingelheim Investigational Site
🇳🇱Breda, Netherlands
1160.71.1349 Boehringer Ingelheim Investigational Site
🇳🇱Den Helder, Netherlands
1160.71.1360 Boehringer Ingelheim Investigational Site
🇳🇱Dirksland, Netherlands
1160.71.1340 Boehringer Ingelheim Investigational Site
🇳🇱Ede, Netherlands
1160.71.1343 Boehringer Ingelheim Investigational Site
🇳🇱Goes, Netherlands
1160.71.1347 Boehringer Ingelheim Investigational Site
🇳🇱Gorinchem, Netherlands
1160.71.1346 Boehringer Ingelheim Investigational Site
🇳🇱Hilversum, Netherlands
1160.71.1339 Boehringer Ingelheim Investigational Site
🇳🇱Hengelo, Netherlands
1160.71.1356 Boehringer Ingelheim Investigational Site
🇳🇱Hoorn, Netherlands
1160.71.1354 Boehringer Ingelheim Investigational Site
🇳🇱Rotterdam, Netherlands
1160.71.1351 Boehringer Ingelheim Investigational Site
🇳🇱Sneek, Netherlands
1160.71.1393 Boehringer Ingelheim Investigational Site
🇳🇴Moss, Norway
1160.71.1424 Boehringer Ingelheim Investigational Site
🇵ðŸ‡Pasig City, Philippines
1160.71.1425 Boehringer Ingelheim Investigational Site
🇵ðŸ‡Quezon City, Philippines
1160.71.1456 Boehringer Ingelheim Investigational Site
🇵🇹Amadora, Portugal
1160.71.1501 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1436 Boehringer Ingelheim Investigational Site
🇵🇱Gdynia, Poland
1160.71.1437 Boehringer Ingelheim Investigational Site
🇵🇱Gdynia, Poland
1160.71.1432 Boehringer Ingelheim Investigational Site
🇵🇱Warsaw, Poland
1160.71.1471 Boehringer Ingelheim Investigational Site
🇷🇴Bucharest, Romania
1160.71.1472 Boehringer Ingelheim Investigational Site
🇷🇴Bucharest, Romania
1160.71.1433 Boehringer Ingelheim Investigational Site
🇵🇱Pulawy, Poland
1160.71.1431 Boehringer Ingelheim Investigational Site
🇵🇱Warsaw, Poland
1160.71.1459 Boehringer Ingelheim Investigational Site
🇵🇹Coimbra, Portugal
1160.71.1504 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1505 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1509 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1511 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1678 Boehringer Ingelheim Investigational Site
🇨🇳Taoyuan, Taiwan
1160.71.1704 Boehringer Ingelheim Investigational Site
🇹ðŸ‡Khon Kaen, Thailand
1160.71.1675 Boehringer Ingelheim Investigational Site
🇨🇳Taipei, Taiwan
1160.71.1676 Boehringer Ingelheim Investigational Site
🇨🇳Taipei, Taiwan
1160.71.1677 Boehringer Ingelheim Investigational Site
🇨🇳Taipei, Taiwan
1160.71.1655 Boehringer Ingelheim Investigational Site
🇨ðŸ‡Bellinzona, Switzerland
1160.71.1651 Boehringer Ingelheim Investigational Site
🇨ðŸ‡Bern, Switzerland
1160.71.1682 Boehringer Ingelheim Investigational Site
🇨🇳Kaohsiung, Taiwan
1160.71.1701 Boehringer Ingelheim Investigational Site
🇹ðŸ‡Bangkok, Thailand
1160.71.1671 Boehringer Ingelheim Investigational Site
🇨🇳Taipei, Taiwan
1160.71.1672 Boehringer Ingelheim Investigational Site
🇨🇳Taipei, Taiwan
1160.71.1681 Boehringer Ingelheim Investigational Site
🇨🇳Tainan, Taiwan
1160.71.1673 Boehringer Ingelheim Investigational Site
🇨🇳Taipei, Taiwan
1160.71.0023 Boehringer Ingelheim Investigational Site
🇺🇸Baltimore, Maryland, United States
1160.71.0079 Boehringer Ingelheim Investigational Site
🇺🇸Baltimore, Maryland, United States
1160.71.0034 Boehringer Ingelheim Investigational Site
🇺🇸Miami, Florida, United States
1160.71.0288 Boehringer Ingelheim Investigational Site
🇺🇸Indianapolis, Indiana, United States
1160.71.0436 Boehringer Ingelheim Investigational Site
🇺🇸Indianapolis, Indiana, United States
1160.71.0402 Boehringer Ingelheim Investigational Site
🇺🇸Cincinnati, Ohio, United States
1160.71.0479 Boehringer Ingelheim Investigational Site
🇺🇸Cincinnati, Ohio, United States
1160.71.0202 Boehringer Ingelheim Investigational Site
🇺🇸Minneapolis, Minnesota, United States
1160.71.0778 Boehringer Ingelheim Investigational Site
🇨🇳QingDao, China
1160.71.0772 Boehringer Ingelheim Investigational Site
🇨🇳Beijing, China
1160.71.0774 Boehringer Ingelheim Investigational Site
🇨🇳Beijing, China
1160.71.0781 Boehringer Ingelheim Investigational Site
🇨🇳Shanghai, China
1160.71.0782 Boehringer Ingelheim Investigational Site
🇨🇳Shanghai, China
1160.71.0780 Boehringer Ingelheim Investigational Site
🇨🇳Shijiazhuang, China
1160.71.0222 Boehringer Ingelheim Investigational Site
🇺🇸Jamestown, North Dakota, United States
1160.71.0701 Boehringer Ingelheim Investigational Site
🇨🇦Portage la Prairie, Manitoba, Canada
1160.71.0441 Boehringer Ingelheim Investigational Site
🇺🇸Carmichael, California, United States
1160.71.0135 Boehringer Ingelheim Investigational Site
🇺🇸Riverside, California, United States
1160.71.0213 Boehringer Ingelheim Investigational Site
🇺🇸Little Rock, Arkansas, United States
1160.71.0191 Boehringer Ingelheim Investigational Site
🇺🇸Little Rock, Arkansas, United States
1160.71.0104 Boehringer Ingelheim Investigational Site
🇺🇸Lake Havasu City, Arizona, United States
1160.71.0115 Boehringer Ingelheim Investigational Site
🇺🇸Mobile, Alabama, United States
1160.71.0070 Boehringer Ingelheim Investigational Site
🇺🇸Merced, California, United States
1160.71.0016 Boehringer Ingelheim Investigational Site
🇺🇸Oceanside, California, United States
1160.71.0384 Boehringer Ingelheim Investigational Site
🇺🇸La Jolla, California, United States
1160.71.0284 Boehringer Ingelheim Investigational Site
🇺🇸San Diego, California, United States
1160.71.0185 Boehringer Ingelheim Investigational Site
🇺🇸Tucson, Arizona, United States
1160.71.0349 Boehringer Ingelheim Investigational Site
🇺🇸Oakland, California, United States
1160.71.0159 Boehringer Ingelheim Investigational Site
🇺🇸Atlanta, Georgia, United States
1160.71.0438 Boehringer Ingelheim Investigational Site
🇺🇸Maywood, Illinois, United States
1160.71.0449 Boehringer Ingelheim Investigational Site
🇺🇸Colorado Springs, Colorado, United States
1160.71.0333 Boehringer Ingelheim Investigational Site
🇺🇸Fullerton, California, United States
1160.71.0339 Boehringer Ingelheim Investigational Site
🇺🇸St. Petersburg, Florida, United States
1160.71.0246 Boehringer Ingelheim Investigational Site
🇺🇸Lancaster, California, United States
1160.71.0152 Boehringer Ingelheim Investigational Site
🇺🇸Oak Lawn, Illinois, United States
1160.71.0379 Boehringer Ingelheim Investigational Site
🇺🇸Walnut Creek, California, United States
1160.71.0362 Boehringer Ingelheim Investigational Site
🇺🇸Fort Collins, Colorado, United States
1160.71.0012 Boehringer Ingelheim Investigational Site
🇺🇸Lakeland, Florida, United States
1160.71.0161 Boehringer Ingelheim Investigational Site
🇺🇸Conyers, Georgia, United States
1160.71.0364 Boehringer Ingelheim Investigational Site
🇺🇸Normal, Illinois, United States
1160.71.0270 Boehringer Ingelheim Investigational Site
🇺🇸Poway, California, United States
1160.71.0074 Boehringer Ingelheim Investigational Site
🇺🇸Fort Myers, Florida, United States
1160.71.0198 Boehringer Ingelheim Investigational Site
🇺🇸Rockford, Illinois, United States
1160.71.0321 Boehringer Ingelheim Investigational Site
🇺🇸Colorado Springs, Colorado, United States
1160.71.0327 Boehringer Ingelheim Investigational Site
🇺🇸Coral Springs, Florida, United States
1160.71.0433 Boehringer Ingelheim Investigational Site
🇺🇸Winfield, Illinois, United States
1160.71.0296 Boehringer Ingelheim Investigational Site
🇺🇸Clearwater, Florida, United States
1160.71.0382 Boehringer Ingelheim Investigational Site
🇺🇸Boynton Beach, Florida, United States
1160.71.0056 Boehringer Ingelheim Investigational Site
🇺🇸Brandon, Florida, United States
1160.71.0541 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
1160.71.0279 Boehringer Ingelheim Investigational Site
🇺🇸Muskegon, Michigan, United States
1160.71.0018 Boehringer Ingelheim Investigational Site
🇺🇸Lafayette, Louisiana, United States
1160.71.0352 Boehringer Ingelheim Investigational Site
🇺🇸Indianapolis, Indiana, United States
1160.71.0377 Boehringer Ingelheim Investigational Site
🇺🇸Fort Wayne, Indiana, United States
1160.71.0089 Boehringer Ingelheim Investigational Site
🇺🇸Jacksonville, Florida, United States
1160.71.0376 Boehringer Ingelheim Investigational Site
🇺🇸Daytona Beach, Florida, United States
1160.71.0331 Boehringer Ingelheim Investigational Site
🇺🇸Melrose Park, Illinois, United States
1160.71.0218 Boehringer Ingelheim Investigational Site
🇺🇸Cicero, Illinois, United States
1160.71.0194 Boehringer Ingelheim Investigational Site
🇺🇸Baltimore, Maryland, United States
1160.71.0020 Boehringer Ingelheim Investigational Site
🇺🇸Troy, Michigan, United States
1160.71.0248 Boehringer Ingelheim Investigational Site
🇺🇸Flemington, New Jersey, United States
1160.71.0472 Boehringer Ingelheim Investigational Site
🇺🇸Woodland Park, New Jersey, United States
1160.71.0064 Boehringer Ingelheim Investigational Site
🇺🇸Yonkers, New York, United States
1160.71.0357 Boehringer Ingelheim Investigational Site
🇺🇸West Des Moines, Iowa, United States
1160.71.0001 Boehringer Ingelheim Investigational Site
🇺🇸West Des Moines, Iowa, United States
1160.71.0445 Boehringer Ingelheim Investigational Site
🇺🇸Petoskey, Michigan, United States
1160.71.0144 Boehringer Ingelheim Investigational Site
🇺🇸Baton Rouge, Louisiana, United States
1160.71.0336 Boehringer Ingelheim Investigational Site
🇺🇸St. Charles, Missouri, United States
1160.71.0235 Boehringer Ingelheim Investigational Site
🇺🇸South Bend, Indiana, United States
1160.71.0132 Boehringer Ingelheim Investigational Site
🇺🇸New Iberia, Louisiana, United States
1160.71.0249 Boehringer Ingelheim Investigational Site
🇺🇸St. Louis, Missouri, United States
1160.71.0114 Boehringer Ingelheim Investigational Site
🇺🇸Annapolis, Maryland, United States
1160.71.0101 Boehringer Ingelheim Investigational Site
🇺🇸St. Paul, Minnesota, United States
1160.71.0452 Boehringer Ingelheim Investigational Site
🇺🇸Haverhill, Massachusetts, United States
1160.71.0154 Boehringer Ingelheim Investigational Site
🇺🇸Grand Blanc, Michigan, United States
1160.71.0274 Boehringer Ingelheim Investigational Site
🇺🇸Rochester Hills, Michigan, United States
1160.71.0229 Boehringer Ingelheim Investigational Site
🇺🇸Mineola, New York, United States
1160.71.0080 Boehringer Ingelheim Investigational Site
🇺🇸Charlotte, North Carolina, United States
1160.71.0165 Boehringer Ingelheim Investigational Site
🇺🇸Saginaw, Michigan, United States
1160.71.0295 Boehringer Ingelheim Investigational Site
🇺🇸Camp Hill, Pennsylvania, United States
1160.71.0142 Boehringer Ingelheim Investigational Site
🇺🇸Browns Mills, New Jersey, United States
1160.71.0069 Boehringer Ingelheim Investigational Site
🇺🇸Statesville, North Carolina, United States
1160.71.0478 Boehringer Ingelheim Investigational Site
🇺🇸Oakland, New Jersey, United States
1160.71.0267 Boehringer Ingelheim Investigational Site
🇺🇸Columbus, Ohio, United States
1160.71.0113 Boehringer Ingelheim Investigational Site
🇺🇸Bronx, New York, United States
1160.71.0301 Boehringer Ingelheim Investigational Site
🇺🇸Allentown, Pennsylvania, United States
1160.71.0350 Boehringer Ingelheim Investigational Site
🇺🇸Gastonia, North Carolina, United States
1160.71.0006 Boehringer Ingelheim Investigational Site
🇺🇸Pinehurst, North Carolina, United States
1160.71.0275 Boehringer Ingelheim Investigational Site
🇺🇸Sandusky, Ohio, United States
1160.71.0369 Boehringer Ingelheim Investigational Site
🇺🇸Jenkintown, Pennsylvania, United States
1160.71.0510 Boehringer Ingelheim Investigational Site
🇦🇺Gosford, New South Wales, Australia
1160.71.0428 Boehringer Ingelheim Investigational Site
🇺🇸Fredericksburg, Virginia, United States
1160.71.0223 Boehringer Ingelheim Investigational Site
🇺🇸Lorain, Ohio, United States
1160.71.0294 Boehringer Ingelheim Investigational Site
🇺🇸Hershey, Pennsylvania, United States
1160.71.0465 Boehringer Ingelheim Investigational Site
🇺🇸Uniontown, Pennsylvania, United States
1160.71.0474 Boehringer Ingelheim Investigational Site
🇺🇸Clinton, Tennessee, United States
1160.71.0353 Boehringer Ingelheim Investigational Site
🇺🇸Asheville, North Carolina, United States
1160.71.0203 Boehringer Ingelheim Investigational Site
🇺🇸Akron, Ohio, United States
1160.71.0201 Boehringer Ingelheim Investigational Site
🇺🇸Kettering, Ohio, United States
1160.71.0103 Boehringer Ingelheim Investigational Site
🇺🇸Westlake, Ohio, United States
1160.71.0139 Boehringer Ingelheim Investigational Site
🇺🇸Corvallis, Oregon, United States
1160.71.0008 Boehringer Ingelheim Investigational Site
🇺🇸Summerville, South Carolina, United States
1160.71.0483 Boehringer Ingelheim Investigational Site
🇺🇸Killeen, Texas, United States
1160.71.0447 Boehringer Ingelheim Investigational Site
🇺🇸Houston, Texas, United States
1160.71.0453 Boehringer Ingelheim Investigational Site
🇺🇸Charlottesville, Virginia, United States
1160.71.0208 Boehringer Ingelheim Investigational Site
🇺🇸Sellersville, Pennsylvania, United States
1160.71.0285 Boehringer Ingelheim Investigational Site
🇺🇸San Marcos, Texas, United States
1160.71.0007 Boehringer Ingelheim Investigational Site
🇺🇸Beaufort, South Carolina, United States
1160.71.0506 Boehringer Ingelheim Investigational Site
🇦🇺Milton, Queensland, Australia
1160.71.0099 Boehringer Ingelheim Investigational Site
🇺🇸Madison, Wisconsin, United States
1160.71.0307 Boehringer Ingelheim Investigational Site
🇺🇸San Antonio, Texas, United States
1160.71.0053 Boehringer Ingelheim Investigational Site
🇺🇸Chesapeake, Virginia, United States
1160.71.0040 Boehringer Ingelheim Investigational Site
🇺🇸Burien, Washington, United States
1160.71.0315 Boehringer Ingelheim Investigational Site
🇺🇸Fort Worth, Texas, United States
1160.71.0508 Boehringer Ingelheim Investigational Site
🇦🇺Coffs Harbour, New South Wales, Australia
1160.71.0410 Boehringer Ingelheim Investigational Site
🇺🇸Austin, Texas, United States
1160.71.0050 Boehringer Ingelheim Investigational Site
🇺🇸Bellingham, Washington, United States
1160.71.0224 Boehringer Ingelheim Investigational Site
🇺🇸Suffolk, Virginia, United States
1160.71.0545 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
1160.71.0367 Boehringer Ingelheim Investigational Site
🇺🇸Tyler, Texas, United States
1160.71.0250 Boehringer Ingelheim Investigational Site
🇺🇸Spokane, Washington, United States
1160.71.0317 Boehringer Ingelheim Investigational Site
🇺🇸Winchester, Virginia, United States
1160.71.0311 Boehringer Ingelheim Investigational Site
🇺🇸Harrisonburg, Virginia, United States
1160.71.0568 Boehringer Ingelheim Investigational Site
🇧🇪Hasselt, Belgium
1160.71.0612 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
1160.71.0615 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
1160.71.0618 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
1160.71.0647 Boehringer Ingelheim Investigational Site
🇧🇷São José do Rio Preto, Brazil
1160.71.0579 Boehringer Ingelheim Investigational Site
🇧🇪Liège, Belgium
1160.71.0678 Boehringer Ingelheim Investigational Site
🇨🇦Saskatoon, Saskatchewan, Canada
1160.71.0932 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
1160.71.0934 Boehringer Ingelheim Investigational Site
🇩🇪Essen, Germany
1160.71.0814 Boehringer Ingelheim Investigational Site
🇨🇿Plzen-Bory, Czech Republic
1160.71.0812 Boehringer Ingelheim Investigational Site
🇨🇿Praha 6, Czech Republic
1160.71.0776 Boehringer Ingelheim Investigational Site
🇨🇳Haerbin, China
1160.71.0784 Boehringer Ingelheim Investigational Site
🇨🇳Hangzhou, China
1160.71.0777 Boehringer Ingelheim Investigational Site
🇨🇳Shenyang, China
1160.71.0840 Boehringer Ingelheim Investigational Site
🇩🇰Køge, Denmark
1160.71.0713 Boehringer Ingelheim Investigational Site
🇨🇦St. George-de-Beauce, Quebec, Canada
1160.71.0675 Boehringer Ingelheim Investigational Site
🇨🇦St. Hyacinthe, Quebec, Canada
1160.71.0673 Boehringer Ingelheim Investigational Site
🇨🇦Saskatoon, Saskatchewan, Canada
1160.71.0773 Boehringer Ingelheim Investigational Site
🇨🇳Beijing, China
1160.71.0811 Boehringer Ingelheim Investigational Site
🇨🇿Praha 5, Czech Republic
1160.71.0700 Boehringer Ingelheim Investigational Site
🇨🇦Quebec, Canada
1160.71.0771 Boehringer Ingelheim Investigational Site
🇨🇳Beijing, China
1160.71.0813 Boehringer Ingelheim Investigational Site
🇨🇿Praha 9, Czech Republic
1160.71.875A Boehringer Ingelheim Investigational Site
🇫🇷ABBEVILLE cedex, France
1160.71.882G Boehringer Ingelheim Investigational Site
🇫🇷Angers, France
1160.71.879F Boehringer Ingelheim Investigational Site
🇫🇷Besle Sur Vilaine, France
1160.71.0852 Boehringer Ingelheim Investigational Site
🇫🇮Tampere, Finland
1160.71.0853 Boehringer Ingelheim Investigational Site
🇫🇮Turku, Finland
1160.71.0963 Boehringer Ingelheim Investigational Site
🇩🇪Köln, Germany
1160.71.0948 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
1160.71.0945 Boehringer Ingelheim Investigational Site
🇩🇪Mannheim, Germany
1160.71.0946 Boehringer Ingelheim Investigational Site
🇩🇪Lahr, Germany
1160.71.0903 Boehringer Ingelheim Investigational Site
🇬🇷Trikala, Greece
1160.71.1582 Boehringer Ingelheim Investigational Site
🇰🇷Seoul, Korea, Republic of
1160.71.1073 Boehringer Ingelheim Investigational Site
🇮🇳Jaipur, Rajasthan, India
1160.71.0962 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
1160.71.0972 Boehringer Ingelheim Investigational Site
🇩🇪Dortmund, Germany
1160.71.1072 Boehringer Ingelheim Investigational Site
🇮🇳Mysore, India
1160.71.1096 Boehringer Ingelheim Investigational Site
🇮🇱Petah Tikva, Israel
1160.71.1592 Boehringer Ingelheim Investigational Site
🇰🇷Seoul, Korea, Republic of
1160.71.1590 Boehringer Ingelheim Investigational Site
🇰🇷Gwangju, Korea, Republic of
1160.71.0901 Boehringer Ingelheim Investigational Site
🇬🇷Athens, Greece
1160.71.0904 Boehringer Ingelheim Investigational Site
🇬🇷Larissa, Greece
1160.71.0937 Boehringer Ingelheim Investigational Site
🇩🇪Witten, Germany
1160.71.0933 Boehringer Ingelheim Investigational Site
🇩🇪Mannheim, Germany
1160.71.1169 Boehringer Ingelheim Investigational Site
🇮🇹Arezzo, Italy
1160.71.1170 Boehringer Ingelheim Investigational Site
🇮🇹Sassari, Italy
1160.71.1586 Boehringer Ingelheim Investigational Site
🇰🇷Cheonan-si, Korea, Republic of
1160.71.1583 Boehringer Ingelheim Investigational Site
🇰🇷Seoul, Korea, Republic of
1160.71.1581 Boehringer Ingelheim Investigational Site
🇰🇷Incheon, Korea, Republic of
1160.71.1591 Boehringer Ingelheim Investigational Site
🇰🇷Daegu, Korea, Republic of
1160.71.1589 Boehringer Ingelheim Investigational Site
🇰🇷Seoul, Korea, Republic of
1160.71.1585 Boehringer Ingelheim Investigational Site
🇰🇷Busan, Korea, Republic of
1160.71.1119 Boehringer Ingelheim Investigational Site
🇮🇱Kfar Saba, Israel
1160.71.1394 Boehringer Ingelheim Investigational Site
🇳🇴RUD, Norway
1160.71.1172 Boehringer Ingelheim Investigational Site
🇮🇹Ascoli Piceno, Italy
1160.71.1584 Boehringer Ingelheim Investigational Site
🇰🇷Daegu, Korea, Republic of
1160.71.1336 Boehringer Ingelheim Investigational Site
🇳🇱Apeldoorn, Netherlands
1160.71.1345 Boehringer Ingelheim Investigational Site
🇳🇱Deventer, Netherlands
1160.71.1338 Boehringer Ingelheim Investigational Site
🇳🇱Enschede, Netherlands
1160.71.1683 Boehringer Ingelheim Investigational Site
🇨🇳Hualien, Taiwan
1160.71.1744 Boehringer Ingelheim Investigational Site
🇬🇧Birmingham, United Kingdom
1160.71.1742 Boehringer Ingelheim Investigational Site
🇬🇧Newcastle upon Tyne, United Kingdom
1160.71.1751 Boehringer Ingelheim Investigational Site
🇬🇧Newport, United Kingdom
1160.71.1743 Boehringer Ingelheim Investigational Site
🇬🇧Romford, Essex, United Kingdom
1160.71.1680 Boehringer Ingelheim Investigational Site
🇨🇳Changhua, Taiwan
1160.71.1679 Boehringer Ingelheim Investigational Site
🇨🇳Taichung, Taiwan
1160.71.1703 Boehringer Ingelheim Investigational Site
🇹ðŸ‡Chiang Mai, Thailand
1160.71.1755 Boehringer Ingelheim Investigational Site
🇬🇧Kirkcaldy, Fife, United Kingdom
1160.71.1745 Boehringer Ingelheim Investigational Site
🇬🇧County Armagh, United Kingdom
1160.71.0395 Boehringer Ingelheim Investigational Site
🇺🇸Nashville, Tennessee, United States
1160.71.0837 Boehringer Ingelheim Investigational Site
🇩🇰Aalborg, Denmark
1160.71.0835 Boehringer Ingelheim Investigational Site
🇩🇰Aarhus C, Denmark
1160.71.0833 Boehringer Ingelheim Investigational Site
🇩🇰Helsingør, Denmark
1160.71.0834 Boehringer Ingelheim Investigational Site
🇩🇰Herlev, Denmark
1160.71.0841 Boehringer Ingelheim Investigational Site
🇩🇰Horsens, Denmark
1160.71.0832 Boehringer Ingelheim Investigational Site
🇩🇰Hvidovre, Denmark
1160.71.0831 Boehringer Ingelheim Investigational Site
🇩🇰Odense, Denmark
1160.71.0836 Boehringer Ingelheim Investigational Site
🇩🇰Svendborg, Denmark
1160.71.882D Boehringer Ingelheim Investigational Site
🇫🇷Angers, France
1160.71.887A Boehringer Ingelheim Investigational Site
🇫🇷Cholet, France
1160.71.879C Boehringer Ingelheim Investigational Site
🇫🇷Derval, France
1160.71.882H Boehringer Ingelheim Investigational Site
🇫🇷Feneu, France
1160.71.888A Boehringer Ingelheim Investigational Site
🇫🇷GRENOBLE Cédex 9, France
1160.71.879B Boehringer Ingelheim Investigational Site
🇫🇷La Chapelle sur Erdre, France
1160.71.874A Boehringer Ingelheim Investigational Site
🇫🇷Langres, France
1160.71.884A Boehringer Ingelheim Investigational Site
🇫🇷Laval, France
1160.71.880B Boehringer Ingelheim Investigational Site
🇫🇷Le Mesnil en Valée, France
1160.71.880A Boehringer Ingelheim Investigational Site
🇫🇷Murs Erigne, France
1160.71.879A Boehringer Ingelheim Investigational Site
🇫🇷Nantes, France
1160.71.879S Boehringer Ingelheim Investigational Site
🇫🇷Nantes, France
1160.71.880J Boehringer Ingelheim Investigational Site
🇫🇷Parcay les Pins, France
1160.71.871A Boehringer Ingelheim Investigational Site
🇫🇷Paris, France
1160.71.880D Boehringer Ingelheim Investigational Site
🇫🇷Segre, France
1160.71.882A Boehringer Ingelheim Investigational Site
🇫🇷Tierce, France
1160.71.882B Boehringer Ingelheim Investigational Site
🇫🇷Tierce, France
1160.71.879G Boehringer Ingelheim Investigational Site
🇫🇷Vieillevigne, France
1160.71.880E Boehringer Ingelheim Investigational Site
🇫🇷Vihiers, France
1160.71.0046 Boehringer Ingelheim Investigational Site
🇺🇸Birmingham, Alabama, United States
1160.71.0211 Boehringer Ingelheim Investigational Site
🇺🇸Birmingham, Alabama, United States
1160.71.0057 Boehringer Ingelheim Investigational Site
🇺🇸Birmingham, Alabama, United States
1160.71.0360 Boehringer Ingelheim Investigational Site
🇺🇸Denver, Colorado, United States
1160.71.0413 Boehringer Ingelheim Investigational Site
🇺🇸Denver, Colorado, United States
1160.71.1746 Boehringer Ingelheim Investigational Site
🇬🇧Chertsey, United Kingdom
1160.71.1741 Boehringer Ingelheim Investigational Site
🇬🇧London, United Kingdom
1160.71.1752 Boehringer Ingelheim Investigational Site
🇬🇧Northampton, United Kingdom
1160.71.1748 Boehringer Ingelheim Investigational Site
🇬🇧York, United Kingdom
1160.71.0702 Boehringer Ingelheim Investigational Site
🇨🇦Cambridge, Ontario, Canada
1160.71.0720 Boehringer Ingelheim Investigational Site
🇨🇦Cambridge, Ontario, Canada
1160.71.0684 Boehringer Ingelheim Investigational Site
🇨🇦Toronto, Ontario, Canada
1160.71.0715 Boehringer Ingelheim Investigational Site
🇨🇦Sudbury, Ontario, Canada
1160.71.0690 Boehringer Ingelheim Investigational Site
🇨🇦Thunder Bay, Ontario, Canada
1160.71.0718 Boehringer Ingelheim Investigational Site
🇨🇦Toronto, Ontario, Canada
1160.71.0686 Boehringer Ingelheim Investigational Site
🇨🇦Windsor, Ontario, Canada
1160.71.0652 Boehringer Ingelheim Investigational Site
🇧🇷Goiania, Brazil
1160.71.0644 Boehringer Ingelheim Investigational Site
🇧🇷Campinas, Brazil
1160.71.0646 Boehringer Ingelheim Investigational Site
🇧🇷Sao Jose do Riio Preto, Brazil
1160.71.0651 Boehringer Ingelheim Investigational Site
🇧🇷Curitiba, Brazil
1160.71.0072 Boehringer Ingelheim Investigational Site
🇺🇸Milwaukee, Wisconsin, United States
1160.71.0951 Boehringer Ingelheim Investigational Site
🇩🇪Mainz, Germany
1160.71.0931 Boehringer Ingelheim Investigational Site
🇩🇪Frankfurt am Main, Germany
1160.71.0943 Boehringer Ingelheim Investigational Site
🇩🇪Heidelberg, Germany
1160.71.0966 Boehringer Ingelheim Investigational Site
🇩🇪Wuppertal, Germany
1160.71.0075 Boehringer Ingelheim Investigational Site
🇺🇸Poughkeepsie, New York, United States
1160.71.0451 Boehringer Ingelheim Investigational Site
🇺🇸Mineola, New York, United States
1160.71.0210 Boehringer Ingelheim Investigational Site
🇺🇸Northport, New York, United States
1160.71.0220 Boehringer Ingelheim Investigational Site
🇺🇸Salem, Virginia, United States
1160.71.0459 Boehringer Ingelheim Investigational Site
🇺🇸Pasadena, California, United States
1160.71.0443 Boehringer Ingelheim Investigational Site
🇺🇸Haverhill, Massachusetts, United States
1160.71.0422 Boehringer Ingelheim Investigational Site
🇺🇸Lexington, Kentucky, United States
1160.71.0325 Boehringer Ingelheim Investigational Site
🇺🇸Eugene, Oregon, United States
1160.71.0133 Boehringer Ingelheim Investigational Site
🇺🇸Springfield, Oregon, United States
1160.71.0173 Boehringer Ingelheim Investigational Site
🇺🇸High Point, North Carolina, United States
1160.71.0232 Boehringer Ingelheim Investigational Site
🇺🇸Jacksonville, Florida, United States
1160.71.0037 Boehringer Ingelheim Investigational Site
🇺🇸Pensacola, Florida, United States
1160.71.0385 Boehringer Ingelheim Investigational Site
🇺🇸Sarasota, Florida, United States
1160.71.0332 Boehringer Ingelheim Investigational Site
🇺🇸Rockledge, Florida, United States
1160.71.0137 Boehringer Ingelheim Investigational Site
🇺🇸Port Charlotte, Florida, United States
1160.71.0461 Boehringer Ingelheim Investigational Site
🇺🇸Milwaukee, Wisconsin, United States
1160.71.0417 Boehringer Ingelheim Investigational Site
🇺🇸Port Charlotte, Florida, United States
1160.71.0021 Boehringer Ingelheim Investigational Site
🇺🇸Augusta, Georgia, United States
1160.71.0109 Boehringer Ingelheim Investigational Site
🇺🇸North Chicago, Illinois, United States
1160.71.0015 Boehringer Ingelheim Investigational Site
🇺🇸St. Petersburg, Florida, United States
1160.71.0268 Boehringer Ingelheim Investigational Site
🇺🇸Dubuque, Iowa, United States
1160.71.0310 Boehringer Ingelheim Investigational Site
🇺🇸Owensboro, Kentucky, United States
1160.71.0427 Boehringer Ingelheim Investigational Site
🇺🇸Jacksonville, Florida, United States
1160.71.0186 Boehringer Ingelheim Investigational Site
🇺🇸Baltimore, Maryland, United States
1160.71.0095 Boehringer Ingelheim Investigational Site
🇺🇸Ormond Beach, Florida, United States
1160.71.0398 Boehringer Ingelheim Investigational Site
🇺🇸Columbia, Maryland, United States
1160.71.0255 Boehringer Ingelheim Investigational Site
🇺🇸Bel Air, Maryland, United States
1160.71.0029 Boehringer Ingelheim Investigational Site
🇺🇸Natick, Massachusetts, United States
1160.71.0308 Boehringer Ingelheim Investigational Site
🇺🇸Worcester, Massachusetts, United States
1160.71.0003 Boehringer Ingelheim Investigational Site
🇺🇸North Dartmouth, Massachusetts, United States
1160.71.0205 Boehringer Ingelheim Investigational Site
🇺🇸Lapeer, Michigan, United States
1160.71.0188 Boehringer Ingelheim Investigational Site
🇺🇸Ypsilanti, Michigan, United States
1160.71.0086 Boehringer Ingelheim Investigational Site
🇺🇸Gulfport, Mississippi, United States
1160.71.0055 Boehringer Ingelheim Investigational Site
🇺🇸Columbia, Missouri, United States
1160.71.0110 Boehringer Ingelheim Investigational Site
🇺🇸Omaha, Nebraska, United States
1160.71.0430 Boehringer Ingelheim Investigational Site
🇺🇸Las Vegas, Nevada, United States
1160.71.0254 Boehringer Ingelheim Investigational Site
🇺🇸Westwood, New Jersey, United States
1160.71.0044 Boehringer Ingelheim Investigational Site
🇺🇸Cortlandt Manor, New York, United States
1160.71.0476 Boehringer Ingelheim Investigational Site
🇺🇸Albany, New York, United States
1160.71.0281 Boehringer Ingelheim Investigational Site
🇺🇸Bronx, New York, United States
1160.71.0183 Boehringer Ingelheim Investigational Site
🇺🇸New Rochelle, New York, United States
1160.71.0356 Boehringer Ingelheim Investigational Site
🇺🇸Watertown, New York, United States
1160.71.0414 Boehringer Ingelheim Investigational Site
🇺🇸Troy, New York, United States
1160.71.0002 Boehringer Ingelheim Investigational Site
🇺🇸Statesville, North Carolina, United States
1160.71.0102 Boehringer Ingelheim Investigational Site
🇺🇸Grand Forks, North Dakota, United States
1160.71.0263 Boehringer Ingelheim Investigational Site
🇺🇸Cleveland, Ohio, United States
1160.71.0480 Boehringer Ingelheim Investigational Site
🇺🇸Cleveland, Ohio, United States
1160.71.0434 Boehringer Ingelheim Investigational Site
🇺🇸Canal Fulton, Ohio, United States
1160.71.0426 Boehringer Ingelheim Investigational Site
🇺🇸Cincinnati, Ohio, United States
1160.71.0150 Boehringer Ingelheim Investigational Site
🇺🇸Fairview Park, Ohio, United States
1160.71.0035 Boehringer Ingelheim Investigational Site
🇺🇸Dayton, Ohio, United States
1160.71.0214 Boehringer Ingelheim Investigational Site
🇺🇸Lyndhurst, Ohio, United States
1160.71.0168 Boehringer Ingelheim Investigational Site
🇺🇸Langhorne, Pennsylvania, United States
1160.71.0431 Boehringer Ingelheim Investigational Site
🇺🇸Lancaster, Pennsylvania, United States
1160.71.0293 Boehringer Ingelheim Investigational Site
🇺🇸Meadowbrook, Pennsylvania, United States
1160.71.0394 Boehringer Ingelheim Investigational Site
🇺🇸Norristown, Pennsylvania, United States
1160.71.0466 Boehringer Ingelheim Investigational Site
🇺🇸Pittsburgh, Pennsylvania, United States
1160.71.0067 Boehringer Ingelheim Investigational Site
🇺🇸Wyomissing, Pennsylvania, United States
1160.71.0032 Boehringer Ingelheim Investigational Site
🇺🇸Wynnewood, Pennsylvania, United States
1160.71.0166 Boehringer Ingelheim Investigational Site
🇺🇸Spartanburg, South Carolina, United States
1160.71.0062 Boehringer Ingelheim Investigational Site
🇺🇸Germantown, Tennessee, United States
1160.71.0129 Boehringer Ingelheim Investigational Site
🇺🇸Austin, Texas, United States
1160.71.0370 Boehringer Ingelheim Investigational Site
🇺🇸Johnson City, Tennessee, United States
1160.71.0156 Boehringer Ingelheim Investigational Site
🇺🇸Dallas, Texas, United States
1160.71.0335 Boehringer Ingelheim Investigational Site
🇺🇸Lubbock, Texas, United States
1160.71.0269 Boehringer Ingelheim Investigational Site
🇺🇸San Antonio, Texas, United States
1160.71.0292 Boehringer Ingelheim Investigational Site
🇺🇸Newport News, Virginia, United States
1160.71.0256 Boehringer Ingelheim Investigational Site
🇺🇸Tacoma, Washington, United States
1160.71.0024 Boehringer Ingelheim Investigational Site
🇺🇸Wenatchee, Washington, United States
1160.71.0547 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
1160.71.0365 Boehringer Ingelheim Investigational Site
🇺🇸Huntington, West Virginia, United States
1160.71.0509 Boehringer Ingelheim Investigational Site
🇦🇺Ashford, South Australia, Australia
1160.71.0504 Boehringer Ingelheim Investigational Site
🇦🇺Box Hill, Victoria, Australia
1160.71.0501 Boehringer Ingelheim Investigational Site
🇦🇺Geelong, Victoria, Australia
1160.71.0543 Boehringer Ingelheim Investigational Site
🇦🇹Graz, Austria
1160.71.0549 Boehringer Ingelheim Investigational Site
🇦🇹Linz, Austria
1160.71.0542 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
1160.71.0548 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
1160.71.0550 Boehringer Ingelheim Investigational Site
🇦🇹Wr. Neustadt, Austria
1160.71.0564 Boehringer Ingelheim Investigational Site
🇧🇪Aalst, Belgium
1160.71.0581 Boehringer Ingelheim Investigational Site
🇧🇪Bruxelles, Belgium
1160.71.0572 Boehringer Ingelheim Investigational Site
🇧🇪Brasschaat, Belgium
1160.71.0585 Boehringer Ingelheim Investigational Site
🇧🇪Bruxelles, Belgium
1160.71.0563 Boehringer Ingelheim Investigational Site
🇧🇪Edegem, Belgium
1160.71.0574 Boehringer Ingelheim Investigational Site
🇧🇪Gent, Belgium
1160.71.0561 Boehringer Ingelheim Investigational Site
🇧🇪Leuven, Belgium
1160.71.0650 Boehringer Ingelheim Investigational Site
🇧🇷Curitiba, Brazil
1160.71.0643 Boehringer Ingelheim Investigational Site
🇧🇷São Paulo, Brazil
1160.71.0611 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
1160.71.0620 Boehringer Ingelheim Investigational Site
🇧🇬Pleven, Bulgaria
1160.71.0694 Boehringer Ingelheim Investigational Site
🇨🇦Calgary, Alberta, Canada
1160.71.0625 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
1160.71.0696 Boehringer Ingelheim Investigational Site
🇨🇦Calgary, Alberta, Canada
1160.71.0712 Boehringer Ingelheim Investigational Site
🇨🇦Coquitlam, British Columbia, Canada
1160.71.0680 Boehringer Ingelheim Investigational Site
🇨🇦Coquitlam, British Columbia, Canada
1160.71.0706 Boehringer Ingelheim Investigational Site
🇨🇦Kelowna, British Columbia, Canada
1160.71.0691 Boehringer Ingelheim Investigational Site
🇨🇦New Westminster, British Columbia, Canada
1160.71.0714 Boehringer Ingelheim Investigational Site
🇨🇦Victoria, British Columbia, Canada
1160.71.0725 Boehringer Ingelheim Investigational Site
🇨🇦Nanaimo, British Columbia, Canada
1160.71.0674 Boehringer Ingelheim Investigational Site
🇨🇦Burlington, Ontario, Canada
1160.71.0692 Boehringer Ingelheim Investigational Site
🇨🇦Grimsby, Ontario, Canada
1160.71.0697 Boehringer Ingelheim Investigational Site
🇨🇦Hamilton, Ontario, Canada
1160.71.0719 Boehringer Ingelheim Investigational Site
🇨🇦Hamilton, Ontario, Canada
1160.71.0721 Boehringer Ingelheim Investigational Site
🇨🇦Hamilton, Ontario, Canada
1160.71.0710 Boehringer Ingelheim Investigational Site
🇨🇦Hamilton, Ontario, Canada
1160.71.0708 Boehringer Ingelheim Investigational Site
🇨🇦Mississauga, Ontario, Canada
1160.71.0688 Boehringer Ingelheim Investigational Site
🇨🇦Newmarket, Ontario, Canada
1160.71.0672 Boehringer Ingelheim Investigational Site
🇨🇦Oshawa, Ontario, Canada
1160.71.0687 Boehringer Ingelheim Investigational Site
🇨🇦Ottawa, Ontario, Canada
1160.71.0723 Boehringer Ingelheim Investigational Site
🇨🇦Scarborough, Ontario, Canada
1160.71.0679 Boehringer Ingelheim Investigational Site
🇨🇦Scarborough, Ontario, Canada
1160.71.0683 Boehringer Ingelheim Investigational Site
🇨🇦Montreal, Quebec, Canada
1160.71.0705 Boehringer Ingelheim Investigational Site
🇨🇦Montreal, Quebec, Canada
1160.71.0709 Boehringer Ingelheim Investigational Site
🇨🇦Montreal, Quebec, Canada
1160.71.0716 Boehringer Ingelheim Investigational Site
🇨🇦Montreal, Quebec, Canada
1160.71.0717 Boehringer Ingelheim Investigational Site
🇨🇦Quebec City, Quebec, Canada
1160.71.0820 Boehringer Ingelheim Investigational Site
🇨🇿Ostrava 1, Czech Republic
1160.71.0838 Boehringer Ingelheim Investigational Site
🇩🇰Frederikssund, Denmark
1160.71.0839 Boehringer Ingelheim Investigational Site
🇩🇰Roskilde, Denmark
1160.71.882K Boehringer Ingelheim Investigational Site
🇫🇷Château Gontier, France
1160.71.0940 Boehringer Ingelheim Investigational Site
🇩🇪Bochum, Germany
1160.71.879H Boehringer Ingelheim Investigational Site
🇫🇷Nantes, France
1160.71.882C Boehringer Ingelheim Investigational Site
🇫🇷Tierce, France
1160.71.879E Boehringer Ingelheim Investigational Site
🇫🇷Saint Aubin Des Chateaux, France
1160.71.0944 Boehringer Ingelheim Investigational Site
🇩🇪Limburg, Germany
1160.71.0970 Boehringer Ingelheim Investigational Site
🇩🇪Mannheim, Germany
1160.71.0914 Boehringer Ingelheim Investigational Site
🇬🇷Kalamaria-Thessaloniki, Greece
1160.71.1017 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºKomarom, Hungary
1160.71.1011 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡ºBudapest, Hungary
1160.71.1056 Boehringer Ingelheim Investigational Site
🇮🇳Ahmedabad-52, India
1160.71.1057 Boehringer Ingelheim Investigational Site
🇮🇳Ahmedabad, India
1160.71.1068 Boehringer Ingelheim Investigational Site
🇮🇳Kottayam, India
1160.71.1055 Boehringer Ingelheim Investigational Site
🇮🇳Lucknow, Uttar Pradesh, India
1160.71.1059 Boehringer Ingelheim Investigational Site
🇮🇳Nagpur-12, India
1160.71.1051 Boehringer Ingelheim Investigational Site
🇮🇳Ludhiana, India
1160.71.1110 Boehringer Ingelheim Investigational Site
🇮🇱Afula, Israel
1160.71.1052 Boehringer Ingelheim Investigational Site
🇮🇳New Delhi, India
1160.71.1070 Boehringer Ingelheim Investigational Site
🇮🇳Pune, Maharashtra, India
1160.71.1121 Boehringer Ingelheim Investigational Site
🇮🇱Afula, Israel
1160.71.1111 Boehringer Ingelheim Investigational Site
🇮🇱Ashkelon, Israel
1160.71.1112 Boehringer Ingelheim Investigational Site
🇮🇱Hadera, Israel
1160.71.1117 Boehringer Ingelheim Investigational Site
🇮🇱Givatayim, Israel
1160.71.1114 Boehringer Ingelheim Investigational Site
🇮🇱Haifa, Israel
1160.71.1116 Boehringer Ingelheim Investigational Site
🇮🇱Haifa, Israel
1160.71.1104 Boehringer Ingelheim Investigational Site
🇮🇱Jerusalem, Israel
1160.71.1106 Boehringer Ingelheim Investigational Site
🇮🇱Jerusalem, Israel
1160.71.1105 Boehringer Ingelheim Investigational Site
🇮🇱Holon, Israel
1160.71.1118 Boehringer Ingelheim Investigational Site
🇮🇱Haifa, Israel
1160.71.1593 Boehringer Ingelheim Investigational Site
🇰🇷Seoul, Korea, Republic of
1160.71.1344 Boehringer Ingelheim Investigational Site
🇳🇱Almelo, Netherlands
1160.71.1331 Boehringer Ingelheim Investigational Site
🇳🇱Amsterdam, Netherlands
1160.71.1358 Boehringer Ingelheim Investigational Site
🇳🇱Eindhoven, Netherlands
1160.71.1333 Boehringer Ingelheim Investigational Site
🇳🇱Groningen, Netherlands
1160.71.1361 Boehringer Ingelheim Investigational Site
🇳🇱Heerlen, Netherlands
1160.71.1359 Boehringer Ingelheim Investigational Site
🇳🇱Maastricht, Netherlands
1160.71.1341 Boehringer Ingelheim Investigational Site
🇳🇱Meppel, Netherlands
1160.71.1353 Boehringer Ingelheim Investigational Site
🇳🇱Tiel, Netherlands
1160.71.1352 Boehringer Ingelheim Investigational Site
🇳🇱Tilburg, Netherlands
1160.71.1350 Boehringer Ingelheim Investigational Site
🇳🇱Veldhoven, Netherlands
1160.71.1348 Boehringer Ingelheim Investigational Site
🇳🇱Zwijndrecht, Netherlands
1160.71.1342 Boehringer Ingelheim Investigational Site
🇳🇱Velp, Netherlands
1160.71.1396 Boehringer Ingelheim Investigational Site
🇳🇴Gjøvik, Norway
1160.71.1391 Boehringer Ingelheim Investigational Site
🇳🇴Oslo, Norway
1160.71.1397 Boehringer Ingelheim Investigational Site
🇳🇴Oslo, Norway
1160.71.1395 Boehringer Ingelheim Investigational Site
🇳🇴Nordbyhagen, Norway
1160.71.1422 Boehringer Ingelheim Investigational Site
🇵ðŸ‡Ermita Manila, Philippines
1160.71.1421 Boehringer Ingelheim Investigational Site
🇵ðŸ‡Manila, Philippines
1160.71.1423 Boehringer Ingelheim Investigational Site
🇵ðŸ‡Quezon City, Philippines
1160.71.1438 Boehringer Ingelheim Investigational Site
🇵🇱Gdynia, Poland
1160.71.1434 Boehringer Ingelheim Investigational Site
🇵🇱Zabrze, Poland
1160.71.1451 Boehringer Ingelheim Investigational Site
🇵🇹Carnaxide, Portugal
1160.71.1454 Boehringer Ingelheim Investigational Site
🇵🇹Coimbra, Portugal
1160.71.1457 Boehringer Ingelheim Investigational Site
🇵🇹Covilhã, Portugal
1160.71.1455 Boehringer Ingelheim Investigational Site
🇵🇹Porto, Portugal
1160.71.1503 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1507 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1508 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1512 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
1160.71.1510 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
1160.71.1513 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
1160.71.1531 Boehringer Ingelheim Investigational Site
🇸🇬Singapore, Singapore
1160.71.1548 Boehringer Ingelheim Investigational Site
🇸🇰Banska Bystrica, Slovakia
1160.71.1514 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
1160.71.1541 Boehringer Ingelheim Investigational Site
🇸🇰Bratislava, Slovakia
1160.71.1543 Boehringer Ingelheim Investigational Site
🇸🇰Bratislava, Slovakia
1160.71.1542 Boehringer Ingelheim Investigational Site
🇸🇰Bratislava, Slovakia
1160.71.1550 Boehringer Ingelheim Investigational Site
🇸🇰Kosice, Slovakia
1160.71.1633 Boehringer Ingelheim Investigational Site
🇸🇪Göteborg, Sweden
1160.71.1547 Boehringer Ingelheim Investigational Site
🇸🇰Zilina, Slovakia
1160.71.1627 Boehringer Ingelheim Investigational Site
🇸🇪Malmö, Sweden
1160.71.1625 Boehringer Ingelheim Investigational Site
🇸🇪Norrköping, Sweden
1160.71.1628 Boehringer Ingelheim Investigational Site
🇸🇪Nässjö, Sweden
1160.71.1626 Boehringer Ingelheim Investigational Site
🇸🇪Stockholm, Sweden
1160.71.1634 Boehringer Ingelheim Investigational Site
🇸🇪Stockholm, Sweden
1160.71.1621 Boehringer Ingelheim Investigational Site
🇸🇪Uppsala, Sweden
1160.71.1635 Boehringer Ingelheim Investigational Site
🇸🇪Uppsala, Sweden
1160.71.1622 Boehringer Ingelheim Investigational Site
🇸🇪Västerås, Sweden
1160.71.1624 Boehringer Ingelheim Investigational Site
🇸🇪Umeå, Sweden
1160.71.1652 Boehringer Ingelheim Investigational Site
🇨ðŸ‡Basel, Switzerland
1160.71.1623 Boehringer Ingelheim Investigational Site
🇸🇪Örebro, Sweden
1160.71.1654 Boehringer Ingelheim Investigational Site
🇨ðŸ‡Lugano, Switzerland
1160.71.1674 Boehringer Ingelheim Investigational Site
🇨🇳Taipei, Taiwan
1160.71.0435 Boehringer Ingelheim Investigational Site
🇺🇸Tulsa, Oklahoma, United States
1160.71.0300 Boehringer Ingelheim Investigational Site
🇺🇸Sacramento, California, United States
1160.71.0227 Boehringer Ingelheim Investigational Site
🇺🇸Orlando, Florida, United States
1160.71.0178 Boehringer Ingelheim Investigational Site
🇺🇸Louisville, Kentucky, United States
1160.71.0397 Boehringer Ingelheim Investigational Site
🇺🇸Louisville, Kentucky, United States
1160.71.0257 Boehringer Ingelheim Investigational Site
🇺🇸Kansas City, Missouri, United States
1160.71.0383 Boehringer Ingelheim Investigational Site
🇺🇸Charleston, South Carolina, United States
1160.71.0019 Boehringer Ingelheim Investigational Site
🇺🇸Vero Beach, Florida, United States
1160.71.1003 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡°Kowloon, Hong Kong
1160.71.1004 Boehringer Ingelheim Investigational Site
ðŸ‡ðŸ‡°Kowloon, Hong Kong